Detalles de la búsqueda
1.
The disease burden of paroxysmal nocturnal hemoglobinuria in Denmark: Epidemiology, survival, healthcare resource utilization, costs, treatment gaps, and labor market attachment.
Eur J Haematol
; 112(3): 412-423, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38009907
2.
Pegcetacoplan in paroxysmal nocturnal haemoglobinuria: Its use, its clinical effectiveness, and its influence on health-related quality of life and productivity.
Eur J Haematol
; 112(4): 516-529, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37994576
3.
Fatigue and health-related quality of life in paroxysmal nocturnal haemoglobinuria: A post hoc analysis of the pegcetacoplan PEGASUS trial data.
Eur J Haematol
; 111(1): 72-83, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36965105
4.
The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors in France, Germany and the United Kingdom: Patient-reported insights on symptoms and quality of life.
Eur J Haematol
; 109(4): 351-363, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35746830
5.
The cost-effectiveness of pegcetacoplan in complement treatment-naïve adults with paroxysmal nocturnal hemoglobinuria in the USA.
J Comp Eff Res
; 12(10): e230055, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37655691
6.
Mapping the EORTC QLQ-C30 onto the EQ-5D-5L index for patients with paroxysmal nocturnal hemoglobinuria in France.
J Comp Eff Res
; 12(5): e220178, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37052120
7.
Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison.
Adv Ther
; 40(4): 1571-1589, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36750531
8.
Treatment preferences towards thrombopoietin-receptor agonists for immune thrombocytopenia and experience of disease (TRAPeze): Italy cohort.
Hematology
; 28(1): 2253069, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37680028
9.
Patient preferences and experiences regarding thrombopoietin-receptor agonists for immune thrombocytopenia in The Netherlands (TRAPeze Netherlands study).
Hematology
; 28(1): 2267942, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37818773
10.
The cost-effectiveness, of pegcetacoplan compared with ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria, in a UK setting.
J Comp Eff Res
; 11(13): 969-985, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35796199
11.
The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving C5 inhibitors: clinical outcomes and medical encounters from the patient perspective.
Hematology
; 27(1): 1140-1151, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36165770
12.
Characterization and treatment of immune thrombocytopenia in Europe: a qualitative observational study.
Hematology
; 26(1): 860-869, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34719349
13.
Patient preferences and experiences regarding thrombopoietin-receptor agonists for immune thrombocytopenia in the United Kingdom and Ireland (TRAPeze UK & IE study).
Hematology
; 26(1): 799-808, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34605362
14.
Efficacy and Safety of Avatrombopag in Patients with Chronic Immune Thrombocytopenia: A Systematic Literature Review and Network Meta-Analysis.
Adv Ther
; 38(6): 3113-3128, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33934279
15.
Cost-Effectiveness Analysis of Recombinant Factor VIII Fc-Fusion Protein (rFVIIIFc) for the Treatment of Severe Hemophilia A in Italy Incorporating Real-World Dosing and Joint Health Data.
Pharmacoecon Open
; 4(1): 133-142, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31280415
16.
Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation--results from four European countries.
Eur J Public Health
; 19(6): 650-4, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19491286
17.
A post hoc analysis of Dupuytren contracture treated with collagenase Clostridium histolyticum across disease stages.
J Plast Surg Hand Surg
; 52(5): 301-306, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30039732
18.
Cost-utility analysis of life-long prophylaxis with recombinant factor VIIIFc vs recombinant factor VIII for the management of severe hemophilia A in Sweden.
J Med Econ
; 21(4): 318-325, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29139314
19.
Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison.
Adv Ther
; 40(12): 5591-5595, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37789229
20.
Salmeterol/fluticasone propionate versus fluticasone propionate plus montelukast: a cost-effective comparison for asthma.
Treat Respir Med
; 4(2): 129-38, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15813665